{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:23:57Z","timestamp":1784093037250,"version":"3.55.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mucormycosis is a rare, opportunistic fungal infection with high mortality rates, predominantly affecting immunocompromised patients. Its management is challenging due to diagnostic complexity and limited therapeutic options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study analyzed 21 cases of mucormycosis diagnosed at the University Hospital of Li\u00e8ge between July 2018 and August 2023. Clinical, microbiological, and radiological data were evaluated to identify risk factors, treatment modalities, and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hematological malignancies (82%) and immunosuppressive therapy (53%) were the most common risk factors. Pulmonary involvement occurred in 94% of cases. Liposomal Amphotericin B was the most frequently used antifungal therapy, and surgery improved outcomes in 50% of cases when it was performed. Despite these measures, the mortality rate on day 84 remained significant at 35%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study underscores the challenges of managing mucormycosis in immunocompromised patients. The high mortality rate emphasizes the importance of early diagnosis, tailored antifungal therapy, and standardized treatment protocols to improve survival outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1715663","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:34:51Z","timestamp":1770183291000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel diagnostic approaches and therapeutic management of mucormycosis: insights from a retrospective monocentric cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Othman","family":"Lemhamdi","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Willems","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Baron","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"De Prijck","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Caers","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Bouquegneau","sequence":"additional","affiliation":[{"name":"Division of Nephrology-Dialysis-Transplantation, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Guiot","sequence":"additional","affiliation":[{"name":"Division of Pneumology, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Cousin","sequence":"additional","affiliation":[{"name":"Division of Radiology, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Jadoul","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine and Oncological Imaging, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Rogister","sequence":"additional","affiliation":[{"name":"Division of Otorhinolaryngology, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Frippiat","sequence":"additional","affiliation":[{"name":"Division of Infectiology, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Hayette","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Department of Medicine, National Reference Centre for Mycosis, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"De Voeght","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, University Hospital of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"B1","volume-title":"Textbook of Medical Mycology.","author":"Chander","year":"2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1268840","DOI":"10.3389\/fmed.2023.1268840","article-title":"The outcome and the risk factors of mucormycosis among patients with hematological diseases: a systematic and meta-analysis.","volume":"10","author":"Shen","year":"2023","journal-title":"Front Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3201\/eid1609.100276","article-title":"Increasing incidence of mucormycosis in University Hospital, Belgium.","volume":"16","author":"Saegeman","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007.","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/1469-0691.12563","article-title":"Epidemiology of mucormycosis in Europe.","volume":"20","author":"Petrikkos","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"B6","doi-asserted-by":"publisher","first-page":"ofaa646","DOI":"10.1093\/ofid\/ofaa646","article-title":"Mucormycosis in hematopoietic cell transplant recipients and in patients with hematological malignancies in the era of new antifungal agents.","volume":"8","author":"Miller","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1128\/AAC.04435-14","article-title":"Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.","volume":"59","author":"Espinel-Ingroff","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B9","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B10","first-page":"7581076","article-title":"Consensus conference on acute GVHD grading.","volume":"15","author":"Przepiorka","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: ii. The 2014 Pathology Working Group Report.","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s00330-017-5007-5","article-title":"Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings.","volume":"28","author":"Nam","year":"2018","journal-title":"Eur Radiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13244-021-01109-z","article-title":"Rhino-orbito-cerebral Mucormycosis: pictorial Review.","volume":"12","author":"Pai","year":"2021","journal-title":"Insights Imaging"},{"key":"B14","volume-title":"Severity Grading In Drug Induced Liver Injury.","year":"2012"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.bbmt.2007.08.047","article-title":"A scheme for defining cause of death and its application in the T cell depletion trial.","volume":"13","author":"Copelan","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijid.2021.06.066","article-title":"Clinical and microbiological features and outcomes of mucormycosis in critically ill patients.","volume":"109","author":"Rothe","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of Mucormycosis: an update.","volume":"6","author":"Skiada","year":"2020","journal-title":"J Fungi"},{"key":"B18","doi-asserted-by":"publisher","first-page":"101010","DOI":"10.1016\/j.lanepe.2024.101010","article-title":"Epidemiology and prognostic factors of mucormycosis in France (2012-2022): a cross-sectional study nested in a prospective surveillance programme.","volume":"45","author":"Gouzien","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1093\/cid\/ciy473","article-title":"Breakthrough invasive mold infections in the hematology patient: current concepts and future directions.","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0149108","DOI":"10.1371\/journal.pone.0149108","article-title":"Mucorales-specific T cells in patients with hematologic malignancies.","volume":"11","author":"Potenza","year":"2016","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0009921","DOI":"10.1371\/journal.pntd.0009921","article-title":"COVID-19-associated mucormycosis: evidence-based critical review of an emerging infection burden during the pandemic\u2019s second wave in India.","volume":"15","author":"Aranjani","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium.","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jinf.2020.05.051","article-title":"Evaluation of MucorGenius\u00a7mucorales PCR assay for the diagnosis of pulmonary mucormycosis.","volume":"81","author":"Guegan","year":"2020","journal-title":"J Infect"},{"key":"B24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/jof5040113","article-title":"Serial detection of circulating mucorales DNA in invasive mucormycosis: a retrospective multicenter evaluation.","volume":"5","author":"Mercier","year":"2019","journal-title":"J Fungi"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1016\/S2666-5247(21)00148-8","article-title":"Mucormycosis: time to address this deadly fungal infection.","volume":"2","author":"Stone","year":"2021","journal-title":"Lancet Microbe"},{"key":"B26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/jof5010024","article-title":"Molecular strategies to diagnose mucormycosis.","volume":"5","author":"Millon","year":"2019","journal-title":"J Fungi"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e746","DOI":"10.1128\/JCM.00746-18","article-title":"PCR-based approach targeting mucorales-specific gene family for diagnosis of mucormycosis.","volume":"56","author":"Baldin","year":"2018","journal-title":"J Clin Microbiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/cid\/ciab1066","article-title":"Evaluation of serum mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial.","volume":"75","author":"Millon","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"101520","DOI":"10.1016\/j.mycmed.2024.101520","article-title":"Laboratory practices for the diagnosis and management of mucormycosis in France, 2024.","volume":"34","author":"Millon","year":"2024","journal-title":"J Mycol Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"103115","DOI":"10.1016\/j.eclinm.2025.103115","article-title":"The diagnosis of mucormycosis by PCR in patients at risk: a systematic review and meta-analysis.","volume":"81","author":"Brown","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1038\/s41467-018-07556-5","article-title":"Molecular diagnostics in medical mycology.","volume":"9","author":"Wickes","year":"2018","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1128\/JCM.39.8.2873-2879.2001","article-title":"Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections.","volume":"39","author":"Ferrer","year":"2001","journal-title":"J Clin Microbiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0355323","DOI":"10.1128\/spectrum.03553-23","article-title":"Clinical impact of metagenomic next-generation sequencing of peripheral blood for the diagnosis of invasive mucormycosis: a single-center retrospective study.","volume":"12","author":"Wang","year":"2024","journal-title":"Microbiol Spectr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1210857","DOI":"10.3389\/fcimb.2024.1210857","article-title":"Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant.","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"myae081","DOI":"10.1093\/mmy\/myae081","article-title":"Aspergillosis coinfection in patients with proven mucormycosis.","volume":"62","author":"Ra","year":"2024","journal-title":"Med Mycol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1080921","DOI":"10.3389\/fcimb.2022.1080921","article-title":"Blood Mucorales PCR to track down Aspergillus and Mucorales co-infections in at-risk hematology patients: a case-control study.","volume":"12","author":"Aerts","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1254919","DOI":"10.3389\/fcimb.2023.1254919","article-title":"Mucormycosis in 2023: an update on pathogenesis and management.","volume":"13","author":"Alqarihi","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/myc.12149","article-title":"Prospective antifungal therapy (PATH) alliance(\u00a7) : focus on mucormycosis.","volume":"57","author":"Kontoyiannis","year":"2014","journal-title":"Mycoses"},{"key":"B40","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.","volume":"67","author":"Spellberg","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation.","volume":"117","author":"Ibrahim","year":"2007","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10 mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.","volume":"70","author":"Lanternier","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"B43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13613-021-00818-4","article-title":"Poor outcome associated with mucormycosis in critically ill hematological patients: results of a multicenter study.","volume":"11","author":"Jestin","year":"2021","journal-title":"Ann Intensive Care"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.3324\/haematol.2012.083063","article-title":"Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.","volume":"98","author":"Pagano","year":"2013","journal-title":"Haematologica"},{"key":"B45","doi-asserted-by":"publisher","first-page":"810.e1","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF).","volume":"22","author":"Millon","year":"2016","journal-title":"Clin Microbiol Infect."},{"key":"B46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00259-018-4192-z","article-title":"Role of FDG PET\/CT in monitoring treatment response in patients with invasive fungal infections.","volume":"46","author":"Ankrah","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B47","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on imaging for invasive pulmonary Aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC\/MSGERC.","volume":"72","author":"Alexander","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0018822","DOI":"10.1128\/mmbr.00188-22","article-title":"Molecular mechanisms that govern infection and antifungal resistance in Mucorales.","volume":"88","author":"Lax","year":"2024","journal-title":"Microbiol Mol Biol Rev"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1715663\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:34:53Z","timestamp":1770183293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1715663\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":48,"alternative-id":["10.3389\/fmed.2026.1715663"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1715663","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"article-number":"1715663"}}